HomeUTHR • NASDAQ
add
United Therapeutics Corporation
Previous close
$367.36
Day range
$367.90 - $374.02
Year range
$208.62 - $417.82
Market cap
16.65B USD
Avg Volume
356.09K
P/E ratio
16.39
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 748.90M | 22.89% |
Operating expense | 257.60M | 21.34% |
Net income | 309.10M | 15.51% |
Net profit margin | 41.27 | -6.01% |
Earnings per share | 7.07 | 31.44% |
EBITDA | 427.30M | 25.57% |
Effective tax rate | 20.46% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.33B | 15.68% |
Total assets | 7.12B | 1.42% |
Total liabilities | 1.02B | -22.06% |
Total equity | 6.10B | — |
Shares outstanding | 44.64M | — |
Price to book | 2.69 | — |
Return on assets | 14.74% | — |
Return on capital | 16.07% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 309.10M | 15.51% |
Cash from operations | 377.20M | 8.95% |
Cash from investing | -114.90M | 63.34% |
Cash from financing | -64.10M | -943.42% |
Net change in cash | 198.20M | 390.59% |
Free cash flow | 248.31M | 31.99% |
About
United Therapeutics Corporation is an American publicly traded biotechnology company and public benefit corporation listed on the NASDAQ under the symbol UTHR. It develops novel, life-extending technologies for patients in the areas of lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
Founded
1996
Headquarters
Website
Employees
1,168
